Glucose Metabolism in Outpatients with New-Onset Hypertension in Chinese Han Population

REFERENCES

• Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37(4):1053–1059.
   PubMed Web of Science ®Google Scholar
• Korhonen P, Aarnio P, Saaresranta T, . Glucose homeostasis in hypertensive subjects. Hypertension 2008; 51(4):945–949.
   PubMed Web of Science ®Google Scholar
• Turner R, Holman R, Stratton I, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317(7160):703–713.
   PubMed Web of Science ®Google Scholar
• Jandeleit-Dahm KA, Tikellis C, Reid CM, . Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23(3):463–473.
   PubMed Web of Science ®Google Scholar
• Yagi S, Goto S, Yamamoto T, . Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003; 26(5):383–387.
   PubMed Web of Science ®Google Scholar
• Takada M, Ura N, Higashiura K, . Effects of cilnidipine on muscle fiber composition, capillary density and muscle blood flow in fructose-fed rats. Hypertens Res 2001; 24(5):565–572.
   PubMed Web of Science ®Google Scholar
• Inukai T, Inukai Y, Matsutomo R, . Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism. J Int Med Res 2004; 32(2):206–213.
   PubMed Web of Science ®Google Scholar
• Giorda C, Appendino M. Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 1993; 42(11):1440–1442.
   PubMed Web of Science ®Google Scholar
• Lithell HO. Hyperinsulinemia, insulin resistance, and the treatment of hypertension. Am J Hypertens 1996; 9(11):150S–154S.
   PubMed Web of Science ®Google Scholar
• Williams WR, Schneider KA, Borhani NO, . The relationship between diuretics and serum cholesterol in hypertension detection and follow-up program participants. Am J Prev Med 1986; 2(5):248–255.
   PubMed Web of Science ®Google Scholar
• Mancia G, Volpe R, Boros S, . Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004; 22(1):51–57.
   PubMed Web of Science ®Google Scholar
• Garcia-Puig J, Ruilope LM, Luque M, . Glucose metabolism in patients with essential hypertension. Am J Med 2006; 119(4):318–326.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7):412–419.
   PubMed Web of Science ®Google Scholar
• Baskar V, Kamalakannan D, Holland MR, . The prevalence of hypertension and utilization of antihypertensive therapy in a district diabetes population. Diabetes Care 2002; 25(11):2107–2108.
   PubMed Web of Science ®Google Scholar
• Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004; 291(3):335–342.
   PubMed Web of Science ®Google Scholar
• Salmasi AM, Alimo A, Dancy M. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic. Am J Hypertens 2004; 17(6):483–488.
   PubMed Web of Science ®Google Scholar
• Yang W, Lu J, Weng J, . Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12):1090–1101.
   PubMed Web of Science ®Google Scholar
• Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004; 286(5):H1597–H1602.
   PubMed Web of Science ®Google Scholar
• Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med 2006; 23(10):1130–1135.
   PubMed Web of Science ®Google Scholar
• Levitzky YS, Pencina MJ, D’Agostino RB, . Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008; 51(3):264–270.
   PubMed Web of Science ®Google Scholar
• Chen YX, Wang XQ, Wang JF, . Glucometabolic state of in-hospital patients with primary hypertension in sub-population of partial regions in China. J Hum Hypertens 2008; 22(5):346–351.
   PubMed Web of Science ®Google Scholar
• Nilsson PM, Cifkova R, Kjeldsen SE, . European Society of Hypertension Scientific Newsletter: update on hypertension management: prevention of type 2 diabetes mellitus with antihypertensive drugs. J Hypertens 2006; 24(12):2478–2482.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Grossman E, Leonetti G. Antihypertensive therapy and new onset diabetes. J Hypertens 2004; 22(10):1845–1847.
   PubMed Web of Science ®Google Scholar
• von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metabol 2000; 85(9):3101–3108.
   PubMed Web of Science ®Google Scholar
• Dunstan DW, Zimmet PZ, Welborn TA, . The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25(5):829–834.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Allison G, Abbasi F, . Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004; 53(4):495–499.
   PubMed Web of Science ®Google Scholar
• Lonati C, Morganti A, Comarella L, . Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. J Hypertens 2008; 26(9):1801–1808.
   PubMed Web of Science ®Google Scholar